Abstract:AIMTo construct ltB-ureB fusion gene and its prokaryotic expression system and identify immunity and adjuvanticity of the expressed recombinant protein.METHODSThe ureB gene from a clinical Helicobacter pylori (H pylori) strain Y06 and the ltB gene from Escherichia coli (E. coli) strain 44851 were linked into ltB-ureB fusion gene by PCR. The fusion gene sequence was analyzed after T-A cloning. A prokaryotic recombinant expression vector pET32a inserted with ltB-ureB fusion gene (pET32a-ltB-ureB) was constructed. Expression of the recombinant LTB-UreB protein (rLTB-UreB) in E. coli BL21DE3 induced by isopropylthio-beta-D-galactoside (IPTG) at different concentrations was detected by SDS-PAGE. Western blot assays were used to examine the immunoreaction of rLTB-UreB by a commercial antibody against whole cell of H pylori and a self-prepared rabbit anti-rUreB serum, respectively, and determine the antigenicity of the recombinant protein on inducing specific antibody in rabbits. GM1-ELISA was used to demonstrate the adjuvanticity of rLTB-UreB. Immunoreaction of rLTB-UreB to the UreB antibody positive sera from 125 gastric patients was determined by using ELISA.RESULTSIn comparison with the corresponding sequences of original genes, the nucleotide sequence homologies of the cloned ltB-ureB fusion gene were 100%. IPTG with different dosages of 0.1-1.0 mmol/L could efficiently induce pET32a-ltB-ureB-E.coli BL21DE3 to express the rLTB-UreB. The output of the target recombinant protein expressed by pET32a-ureB-E.coli BL21DE3 was approximately 35% of the total bacterial proteins. rLTB-UreB mainly presented in the form of inclusion body. Western blotting results demonstrated that rLTB-UreB could combine with the commercial antibody against whole cell of H pylori and anti-rUreB serum as well as induce rabbit to produce specific antibody. The strong ability of rLTB-UreB binding bovine GM1 indicated the existence of adjuvanticity of the recombinant protein. All the UreB antibody positive sera from the patients (125/125) were positive for rLTB-UreB.CONCLUSIONA recombinant prokaryotic expression system with high expression efficiency of the target fusion gene ltB-ureB was successfully established. The expressed rLTB-UreB showed qualified immunogenicity, antigenicity and adjuvanticity. All the results mentioned above laid a firm foundation for further development of H pylori genetically engineered vaccine.

Evaluation of the Immunity Effectiveness on the Engineered Subunit Vaccine of Staphylococcus Aureus Α-Hemolysin

Reconstruction of the Heat-Labile Enterotoxin Subunit B Gene of Escherichia Coli and Its Immune Adjuvant Activity on Mucosa

[Prokaryotic Expression of Staphylococcus Aureus Clumping Factor B and Evaluation of the Antiserum-Mediated Opsonic Activity].

Immunoprotection of Recombinant Antigen LTB-UreB-HpaA in Helicobacter Pylori Infected Mice and Immunoenhancement of the Inner Adjuvant LTB

Identification and Immunoprotective Effect of Prokaryotic Expression Product of Ltb-Hpaa Fusion Gene

Construction and identification of prokaryotic expression system of staphylococcal enterotoxin A gene and expressed product

Construction of Prokaryotic Expression System of Ltb-Ureb Fusion Gene and Identification of the Recombinant Protein Immunity and Adjuvanticity

[Immunoprotective Effects of Helicobacter Pylori UreB and HpaA Bivalence Recombinant Vaccine with Inner Adjuvant on Experimental Infection in Mice].

Construction of Prokaryotic Expression System of Staphylococcal Enterotoxin B Gene and Effects of Its Expressed Product on Promoting Lymphocyte Proliferation and Inhibiting the Growth of Tumor Cell

Prokaryotic Expression,Purification and Identification of the Biological Effects of Staphylococcal Enterotoxin B

Cloning, Construction of Prokaryotic Expression System and Identification of Vibrio Vulni Ficus Vvha Gene

Identification and application of a neutralizing epitope within alpha-hemolysin using human serum antibodies elicited by vaccination

[The Immunization Effects of HBV Core Antigen and Surface Antigen Fusion Protein in Mice].

Development of an Aeromonas hydrophila recombinant extracellular protease vaccine

Vaccine display on artificial bacterial spores enhances protective efficacy against Staphylococcus aureus infection

Expression, Purification, and Renaturation of a Recombinant Peptide-Based HIV Vaccine in Escherichia Coli.

Fusion Expression and Immunogenicity of EHEC EspA-Stx2Al Protein: Implications for the Vaccine Development

Preparation of streptococcus pneumococcal autolysin DNA vaccine and study of its immunogenicity

Expression, Purification, and Evaluation of Antibody Responses and Antibody-Immunogen Complex Simulation of a Designed Multi-Epitope Vaccine against SARS-COV-2

[Prokaryotic Expression and Immunogenicity Analysis of the Chimeric HBcAg Containing APP Beta Cleavage Site Peptide and Aβ(1-15);].

[Construction of Recombinant Plasmid Pyta/abeta-Hbcag and Its Expression in E.coli].